Diagnostic assay for Melanoma

Inventor

A/Prof. Melanie Ziman School of Exercise, Biomedical & Health Sciences.

Applications

Pharmaceutical Industry.

IP status

Provisional patent filed.

Current status

A non-invasive blood test for melanoma that reliably detects early stage tumour spread and thus has the potential to improve diagnosis, staging, progression and treatment monitoring.